Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Marinos Fysekidis"'
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0256952 (2021)
An increase in employment rate was observed among individuals who underwent bariatric surgery. This study assessed the relationship between employment rate and weight loss, deprivation, and Bariatric Analysis and Reporting Outcome System (BAROS) scor
Externí odkaz:
https://doaj.org/article/89967d8ea03d458ea91dd6feb53b2db2
Autor:
Katerina krompa, Ines Barka, Stéphanie Malard, Sopio Tatulashvili, Camille Baudry, Hélène Bihan, Marinos Fysekidis
Publikováno v:
The Pan African Medical Journal, Vol 31, Iss 38 (2018)
Patients with ketosis prone diabetes have been reported primarily in Africans and African Americans. At presentation, both insulin secretion and insulin action are impaired in ketosis prone diabetes patients. Fulminant diabetes is a subtype of type 1
Externí odkaz:
https://doaj.org/article/d9b6df39beb14b9798e6bcfb7a0652db
Autor:
Pierre Sabouret, Stéphane Manzo-Silberman, Mirvat Alasnag, Marinos Fysekidis, Martha Gulati, Giuseppe Galati, Luigi Spadafora, Maciej Banach, Giuseppe Biondi-Zoccai, Deepak L Bhatt
Publikováno v:
European Heart Journal Open.
Autor:
Pierre SABOURET, Pier P. BOCCHINO, Filippo ANGELINI, Fabrizio D’ASCENZO, Giuseppe GALATI, Marinos FYSEKIDIS, Gaetano M. DE FERRARI, David L. FISCHMAN, Deepak L. BHATT, Giuseppe BIONDI-ZOCCAI
Publikováno v:
Minerva Cardiology and Angiology. 71
Glucagon-like peptide 1 receptor agonists (GLP1-RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) were individually proven to reduce major adverse cardiovascular events (MACE) in type 2 diabetes mellitus (T2DM) patients, but the relative mag
Autor:
Pierre SABOURET, Denis ANGOULVANT, Atul PATHAK, Marinos FYSEKIDIS, Giulia LATERRA, Francesco COSTA, Filippo ANGELINI, Pier P. BOCCHINO, Gilles MONTALESCOT, Giuseppe BIONDI-ZOCCAI
Publikováno v:
Panminerva Medica. 64
The continuous progress in cardiovascular (CV) risk prevention strategies has led to an impressive reduction in mortality and recurrent ischemic events in patients with coronary artery disease (CAD). However, the control of several CV risk factors re
Autor:
Robert Benamouzig, Pierre Rompteaux, Jean-Jacques Raynaud, Marinos Fysekidis, Jean-Marc Sabate, Michel Bouchoucha
Publikováno v:
Journal of Neurogastroenterology and Motility
Background/aims Self-reported lactose intolerance (LI) is frequent in patients with functional bowel disorders (FBD) that could be interpreted as irritable bowel syndrome (IBS). The present study aims to characterize the responses of patients with FB
Autor:
Denis CHARLES, Pierre SABOURET, Antoine MOLL, Manuel PLISSON, Khurram NASIR, Giuseppe BIONDI-ZOCCAI, Martha GULATI, Deepak L. BHATT, Marinos FYSEKIDIS
Publikováno v:
Panminerva Medica.
Physical activity (PA) is an established modifiable factor for the prevention of cardiovascular disease. Our objective was to assess the association of PA with mortality rates in a national sample of patients with diabetes.We analyzed a nationally re
Autor:
Robert Benamouzig, Michel Bouchoucha, Marinos Fysekidis, David Deutsch, Bakhtiar Bejou, Jean-Marc Sabate
Publikováno v:
Digestive Diseases and Sciences. 66:3588-3596
Constipation is a frequent complaint of patients with functional bowel disorders. The present study aimed to evaluate the relationship between the perceived constipation severity with demographics, clinical, physiological, and psychological parameter
Autor:
E. Chouillard, Rami Dbouk, J.J. Portal, J. Roussel, Yasmina Bendacha, Régis Cohen, Jean Gugenheim, Marinos Fysekidis, Jean-Marc Catheline, M. Sodji, K. Arapis, Simon Msika, J.M. Fabre, E. Vicaut, G. Fourtanier, N. Huten
Publikováno v:
Journal de Chirurgie Viscérale. 156:532-542
Resume Situation La sleeve gastrectomie laparoscopique (SGL) et le bypass gastrique en Y laparoscopique (BPGYL) sont couramment effectues, mais peu d’etudes ont montre la superiorite d’une strategie par rapport a l’autre. Objectif Comparer simu
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases
Nutrition, Metabolism and Cardiovascular Diseases, Elsevier, 2021, 31 (10), pp.2945-2958. ⟨10.1016/j.numecd.2021.06.017⟩
Nutrition, Metabolism and Cardiovascular Diseases, Elsevier, 2021, 31 (10), pp.2945-2958. ⟨10.1016/j.numecd.2021.06.017⟩
Background and aims Studies of dipeptidyl peptidase inhibitors (DPP4is) report heterogeneous effects on cardiovascular targets in type 2 diabetes. This study aimed to investigate, in patients with impaired glucose tolerance (IGT), whether saxagliptin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2a2c323f11622e53a8d5ae887cf7e93
https://hal-cnam.archives-ouvertes.fr/hal-03500288
https://hal-cnam.archives-ouvertes.fr/hal-03500288